Filter
2113
Text search:
controlled
drugs
Featured
Recommendations
251
New Publications
453
Language
Document type
No document type
1198
Guidelines
395
Studies & Reports
287
Manuals
121
Strategic & Response Plan
45
Fact sheets
29
Training Material
23
Situation Updates
6
Brochures
4
Resource Platforms
2
Infographics
2
Countries / Regions
India
137
Global
64
Kenya
55
South Africa
55
Uganda
41
Western and Central Europe
41
Ethiopia
36
Nigeria
34
Tanzania
33
Africa
30
Latin America and the Carribbean
29
Sierra Leone
28
Nepal
28
Malawi
28
Ukraine
27
Zambia
26
Eastern Europe
25
Philippines
22
Rwanda
22
Ghana
20
Liberia
19
Bangladesh
18
Myanmar / Burma
18
Zimbabwe
17
Russia
17
Syria
15
Indonesia
15
Asia
13
Brazil
12
Lesotho
12
South–East Asia Region
12
South Sudan
11
Namibia
11
Eswatini/ Swaziland
11
Mozambique
10
Colombia
9
Burkina Faso
8
Botswana
8
Congo, Democratic Republic of
7
Germany
7
East and Southern Africa
7
Venezuela
7
Guinea
6
Cameroon
6
Afghanistan
6
Yemen
6
Haiti
5
Lebanon
5
Thailand
5
Sudan
5
Tajikistan
5
Senegal
4
Jordan
4
West and Central Africa
4
Eastern Europe and Central Asia
4
North America
4
Mali
3
USA
3
Pakistan
3
Iraq
3
Cambodia
3
Central African Republic
3
Argentina
3
Angola
3
Madagascar
3
Middle East and North Africa
3
Paraguay
3
Iran
3
Georgia
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Somalia
2
Egypt
2
China
2
North Macedonia
2
Hungary
2
Ecuador
2
Libya
2
Mexico
2
Sri Lanka
2
Palestine
2
Albania
2
Canada
2
Lithuania
2
Kyrgyzstan
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
Turkey
1
Singapore
1
Papua New Guinea
1
Benin
1
Peru
1
Serbia
1
Burundi
1
Bolivia
1
Greece
1
Chile
1
Western Pacific Region
1
Bhutan
1
Poland
1
Djibouti
1
Armenia
1
Laos
1
Qatar
1
Moldova
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
691
Clinical Guidelines
288
Public Health
122
Women & Child Health
102
Key Resources
59
Pharmacy & Technologies
27
Capacity Building
22
Toolboxes
Mental Health
289
HIV
236
TB
173
COVID-19
97
NTDs
84
Pharmacy
81
NCDs
80
AMR
67
Caregiver
55
Ebola & Marburg
38
Malaria
37
Conflict
33
Refugee
25
Disability
22
Rapid Response
17
Planetary Health
17
Cholera
14
Global Health Education
14
Natural Hazards
12
Polio
7
Health Financing Toolbox
7
Zika
6
Specific Hazards
6
2.0 Rapid Response
3
Social Ethics
2
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
(Lecture series consist of a total of 59 cha
...
The World Health Organization (WHO) has recommended a universal antiretroviral therapy (ART) for all HIVinfected children before the age of two since 2010, but this implies an early identification of these infants. We described the Prevention of Mother-to-Child HIV Transmission (PMTCT) cascade, the
...
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i
...
ATLAS on substance use (2010) — Resources for the prevention and treatment of substance use disorders
Accessed: 14.03.2019
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi
...